Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BLSH | EXP |
|---|---|---|
| Price | $34.35 | $169.82 |
| Change today | ▲ 0.35% | ▼ 0.90% |
| Market cap | $5.21B | $5.21B |
| Return, 3 months | +33.3% | -20.2% |
| Return, year to date | -9.3% | -17.5% |
| Return, 1 year | -50.1% | -27.7% |
| P/E (TTM) | -3.7 | 13.4 |
| P/B | 2.2 | 3.5 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 0.59% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 49 | 30 |
| 30-day volatility | 73.2% | 20.0% |
| Max drawdown, 1 year | -68.6% | -29.4% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
